Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parenteral Glutamine Supplementation for ELBW Infants
NCT00005775Phase 3Completed
- Sponsor
- NICHD Neonatal Research Network
- Start
- Jul 1999
- Primary completion
- Dec 2000
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in late-onset neonatal sepsis (LONS) comparing Glutamine with Placebo (2 arms). Primary endpoint: Death or late-onset sepsis. Started Jul 1999; status: completed.
02
Drugs
glutamine
03
Conditions
late-onset neonatal sepsis (LONS)
Beyond the preview
Go deeper on NCT00005775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005775.